SCHEMBL1190247

SCHEMBL1190247

O=C1COc2nccc(Cl)c2N1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.38
DAO P14920 1/20 0.34
NR3C2 P08235 2/20 0.33
GRM5 P41594 1/20 0.33
MAPT P10636 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MMP12 P39900 1/20 0.32
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
DRD2 P14416 2/20 0.31
DRD4 P21917 2/20 0.31
DRD3 P35462 2/20 0.31
MALT1 Q9UDY8 2/20 0.31
CYP1A2 P05177 1/20 0.31
ALDH1A1 P00352 1/20 0.31
AURKA O14965 1/20 0.30
AURKB Q96GD4 1/20 0.30
PDE7A Q13946 1/20 0.30
MGLL Q99685 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23318178 0.80 NR3C2 (0.39) NR3C2MMP12CYP11B1CYP11B2DRD2
SCHEMBL32675632 0.80 NR3C2 (0.39) NR3C2MMP12CYP11B1CYP11B2DRD2
SCHEMBL24264971 0.79 PARP1 (0.41) NR3C2MAPTMMP12CYP11B1CYP11B2
SCHEMBL21103829 0.76 ADRB1 (0.36) NR3C2MMP12DRD2DRD4DRD3
SCHEMBL4251063 0.75 MALT1 (0.38) DAONR3C2MAPTTDP1L3MBTL1
SCHEMBL16651977 0.73 MMP12 (0.33) NR3C2MMP12CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL25196791 0.72 MMP12 (0.32) NR3C2MMP12CYP11B1CYP11B2
SCHEMBL26640674 0.71 AKR1B1 (0.30)
SCHEMBL1191593 0.70 MAP4K1 (0.34) DAOGRM5MAPT
SCHEMBL279914 0.69 CYP11B1 (0.44) AHRNR3C2MMP12CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2266989-B1 HETEROCYCLIC DERIVATIVES C & C RES LAB (KR) 2015-09-02 EP disclosed
US-8394792-B2 Heterocyclic derivatives C&C RESEARCH LABORATORIES (KR) 2013-03-12 US disclosed
US-20110028467-A1 HETEROCYCLIC DERIVATIVES C&C RESEARCH LABORATORIES (KR) 2011-02-03 US disclosed
EP-2266989-A2 HETEROCYCLIC DERIVATIVES C&c Research Laboratories (KR) 2010-12-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028467-A1 HETEROCYCLIC DERIVATIVES XDH, NUDT1, UGDH AHR 662/4885DAO 503/4885NR3C2 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.